Once-Weekly Mosnodenvir Effective Against Dengue in Human Model

New research published in The New England Journal of Medicine indicates that once-weekly mosnodenvir effectively prevented dengue in a human infection model. This small-molecule antiviral represents a significant potential advancement, as there is currently no approved antiviral therapy for dengue. The findings could lead to new prophylactic options.